Terra Lasho

Myeloid biologist and Lab Director for the Myeloid Neoplasm Research group at Mayo Clinic. Current research focuses on evolutionary trajectory and translational aspects of myeloid malignancies. Extensive expertise in studying the prognostic relevance of somatic genomic alterations especially in blood neoplasms for cancer prevention and therapeutic vulnerabilities. Manage molecular testing and reporting for the Mayo Pre-Myeloid Bone Marrow Failure Clinic. Background in biochemistry, computational chemistry, and lab-based translational experiment design, combined with effort in co-authoring over 350 peer reviewed publications and many national and international educational appearances, all based on myeloid malignancy research. Successfully led interdisciplinary projects, resulting in significant advancements in field.

• Citizenship: United States of America
• Title: Assistant Professor of Medicine
• Nationality: United States of America

• 2012-13 Associate Faculty, First and Second Annual International Working Group (IWG) Meeting on Myeloproliferative Neoplasms, Florence Italy
• 2013 Keynote Speaker, Myelodysplastic Syndrome (MDS) Conference, Marshfield Clinic, Marshfield WI
• 2013 Invited Speaker, Grand Rounds, Tri Service General-Hospital, Taipei, Taiwan
• 2013 Invited Speaker, Taipei Medical University, Taipei, Taiwan
• 2017 Keynote Speaker, Myeloproliferative Neoplasms Conference, Marshfield Clinic, Marshfield, WI
• 2018 Lecturer –Precision Medicine; Mayo College of Medicine, Rochester, MN
• 2020-2021 Chair of Professional Development, Lab Techniques, RTRG Mayo Clinic
• 2022 Invited Speaker, Diamond Showcase Presenter, Cancer Genetics Consortium, St. Louis, MO
• 2023 Invited Plenary Speaker, CIMCOM Mayo Clinic Annual Meeting, Ponte Vedra Beach, FL
• 2023 Invited Speaker for Educational Session on Clonal Hematopoiesis, for Minnesota Genetic Counselors Association (MNGCA) Education Conference, Minneapolis, MN
• 2024 Invited Plenary Speaker, Japanese Society of Hematology, Kyoto, Japan
• 2024 Invited Speaker, MPN Updates 2024, University of Akita, Akita, Japan
• 2025 Invited Speaker, Education Session, AACR, Chicago, IL

• EPSCoR Undergraduate Research Grant, University of Wyoming, Laramie, Wyoming, 2000-01-01
• Mayo Clinic Research Technologist of the Year, Department of Medicine, Mayo Clinic, Rochester, Minnesota, 2014-01-01
• Career Development Award (Predolin Foundation), Mayo Clinic, Zebrafish Model of Ethanolamine Kinase Mutations in Hematopoietic Disease, 2015-01-01, 2017-01-01
• Pseudo-Mutant p53: a targetable predictor of leukemic transformation in clonal hematopoiesis, Mayo/Karolinska Institute Collaboration Travel Award, Stockholm, Sweden, 2024-01-01

• American Association for the Advancement of Science, Member, 2011 Present
• American Society of Clinical Oncology, Member, 2012, Present
• Annals of Translational Medicine, Editorial Board, 2012-2014
• American Society of Clinical Pathology, Certified Member, 2001, Present
• American Society of Hematology, Student Member, 2012, 2016

• Stemline Therapeutics Sponsored Comprehensive Correlative Studies in the addended phase III STML-04-03 Trial on CMML, Co-Program Director / Principal Investigator, Stemline Therapeutics, Inc., 2020-03-01, 2022-02-01
• 1901 Gangat 9-ING-41 w Ruxo, Co-Investigator, Actuate Therapeutics, 2020-08-01, 2022-08-01
• ROS1 Alterations in Atypical Chronic Myeloid Leukemia, Co-Program Director / Principal Investigator, SGP - Small Grants Program <$10K, 2020-01-01, 2022-01-01